Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

NEA RELIANT HEALTH CARE PROFESSIONALS INC

NPI: 1467829804 · BONO, AR 72416 · Family Nurse Practitioner · NPI assigned 09/01/2015

$1.86M
Total Medicaid Paid
79,769
Total Claims
67,774
Beneficiaries
82
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialBERGMAN, JEREMY (OWNER)
NPI Enumeration Date09/01/2015

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 15,581 $186K
2019 10,445 $146K
2020 11,623 $370K
2021 17,674 $592K
2022 10,096 $332K
2023 8,831 $129K
2024 5,519 $103K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 15,958 12,599 $516K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 9,982 9,139 $463K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 9,116 8,104 $380K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 10,672 9,151 $252K
80305 7,347 5,681 $20K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 160 133 $14K
80348 585 554 $12K
80346 585 554 $12K
80354 583 553 $12K
80373 584 554 $11K
80370 584 554 $10K
80364 480 449 $9K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 572 542 $9K
80325 585 555 $9K
80355 588 556 $8K
80368 585 554 $8K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 353 311 $8K
80349 584 554 $7K
80366 548 518 $7K
80323 237 220 $7K
80358 349 326 $7K
80365 363 330 $6K
80353 345 324 $5K
80360 335 312 $5K
80338 222 207 $4K
81003 5,508 4,328 $4K
99406 481 391 $4K
93880 28 26 $4K
80357 222 207 $3K
80359 222 207 $3K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 211 177 $3K
80356 109 102 $2K
80061 Lipid panel 403 318 $2K
80053 Comprehensive metabolic panel 616 497 $2K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 862 689 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 300 180 $2K
99454 126 119 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,707 1,549 $2K
80362 363 330 $2K
71046 Radiologic examination, chest; 2 views 129 104 $2K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 19 16 $2K
80050 General health panel 53 42 $2K
83036 Hemoglobin; glycosylated (A1C) 319 247 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 296 195 $1K
84439 213 174 $1K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 78 50 $1K
82607 137 114 $976.41
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 17 13 $715.51
84480 48 45 $445.50
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 17 16 $326.92
99491 Ccm add 20min 36 30 $312.66
94010 19 15 $280.11
99407 24 13 $275.00
72100 25 14 $250.52
83735 69 56 $241.62
84436 49 45 $195.80
36415 Collection of venous blood by venipuncture 366 321 $184.77
99490 Ccm add 20min 21 21 $139.50
80048 Basic metabolic panel (calcium, ionized) 32 30 $132.99
99457 125 120 $103.47
86140 47 42 $81.66
85651 58 40 $77.18
84443 Thyroid stimulating hormone (TSH) 31 27 $58.51
80076 13 13 $58.35
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 18 13 $31.68
96127 19 12 $29.37
3078F 34 31 $10.00
3074F 143 129 $10.00
96160 61 42 $0.51
1159F 953 840 $0.00
1160F 1,015 889 $0.00
99487 Ccm add 20min 16 12 $0.00
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 18 14 $0.00
3008F 716 623 $0.00
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 29 19 $0.00
1125F 685 610 $0.00
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 69 27 $0.00
1126F 124 107 $0.00
1170F 85 77 $0.00
3079F 55 46 $0.00
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 13 12 $0.00
94760 15 14 $0.00